Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line

Journal of Pharmaceutical and Biomedical Analysis

Volumn 84, Issue , 2013, Pages 112-116

  Daruházi, Ágnes Emma ^a   Kiss, Tímea ^b   Vecsernyés, Miklós ^b   Szente, Lajos ^c   Szoke, Éva ^a   Lemberkovics, Éva ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

Caco 2; Cyclodextrin; Daidzein; Dissolution profile; Genistein

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; AGLYCONE; BETA CYCLODEXTRIN; CYCLODEXTRIN; DAIDZEIN; GAMMA CYCLODEXTRIN; GENISTEIN; ISOFLAVONE; METHYL BETA CYCLODEXTRIN;

ARTICLE; CELL STRAIN CACO 2; DISSOLUTION; DRUG SOLUBILITY; DRUG STRUCTURE; ENCAPSULATION; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SOLID;

CACO-2; CYCLODEXTRIN; DAIDZEIN; DISSOLUTION PROFILE; GENISTEIN;

BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL LINE, TUMOR; CYCLODEXTRINS; GENISTEIN; HUMANS; ISOFLAVONES; PERMEABILITY; SOLUBILITY;

EID: 84879763230     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.05.012     Document Type: Article

References (20)

1. Veitch N.C. Isoflavonoids of the Leguminosae. Nat. Prod. Rep. 2007, 24:417-464.
2. Lapčík O. Isoflavonoids in non-leguminous taxa: a rarity or a rule. Phytochemistry 2007, 68:2909-2916.
3. Beck V. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?. Steroid Biochem. Mol. Biol. 2005, 94:499-518.
4. Cherdshewasart W., Panriansaen R., Picha P. Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence and exhibits lower profile of mammary ERα and ERβ. Maturitas 2007, 58:174-181.
5. Atkinson C., Frankenfeld C.L., Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. 2005, 230:155-170.
6. Kerry N., Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 1998, 140:341-347.
7. Iovine B., Iannella M.L., Gasparri F., Monfrecola G., Bevilacqua M.A. Synergic effect of genistein and daidzein on UVB-induced DNA damage: an effective photoprotective combination. J. Biomed. Biotechnol. 2011, 692846. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139128/.
8. Hämäläinen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-kB activation whereas flavone, isorhamnetin, naringenin and pelargonidin inhibit only NF-kB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007, 2007:1-10.
9. Dobrydevna Y., Williams R.L., Morris G.Z., Blackmore P.F. Dietary phytoestrogens and their synthetic structural analogues as calcium channel blockers in human platelets. J. Cardiovasc. Pharmacol. 2002, 40:399-410.
10. Stancanelli R., Mazzaglia M., Tommasini S., Calabro M.L., Villari V., Guardo M., Ficarra P., Ficarra R. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis. J. Pharm. Biomed. Anal. 2007, 44:980-984.
11. Cannava C., Crupi V., Ficarra P., Guardo M., Majolino D., Mazzaglia A., Stancanelli R., Venuti V. Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex. J. Pharm. Biomed. Anal. 2010, 51:1064-1068.
12. Crupi V., Ficarra R., Guardo M., Majolino D., Stancanelli R., Venuti V. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrins. J. Pharm. Biomed. Anal. 2007, 44:110-117.
13. S. Kanaoka, et al., European Patent Application, EP 796624, 1997.
14. Loftsson T., Jarho P., Másson M., Järvinen T. Cyclodextrins in drug delivery. Expert Opin. Drug. Deliv. 2005, 2:335-351.
15. Steensma A., Noteborn H.P.J.M., Kuiper H.A. Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides. Environ. Toxcol. Pharm. 2004, 16:131-139.
16. Steensma A., Noteborn H.P.J.M., van der Jagt R.C.M., Polman T.H.G., Mengelers M.J.B., Kuiper H.A. Bioavailability of genistein, daidzein, and their glycosides in intestinal epithelial Caco-2 cells. Environ. Toxicol. Pharm. 1999, 7:209-212.
17. Szejtli J. Comprehensive Supramolecular Chemistry 1996, vol. 3:14-26. Elsevier Science Ltd., Oxford.
18. Weiszfeiler V., Stadler-Szoke A., Szejtli J. Proceedings of the International Symposium on Cyclodextrin 1988, 329-335. Kluwer, Dordrecht, Netherlands. O. Huber, J. Szejtli (Eds.).
19. Messner M., Kurkov S.V., Jansook P., Loftsson T. Self-assembled cyclodextrin aggregates and nanoparticles. Int. J. Pharm. 2010, 387:199-208.
20. Fenyvesi F., Kiss T., Fenyvesi E., Szente L., Veszelka S., Deli M.A., Váradi J., Fehér P., Ujhelyi Z., Tósaki A., Vecsernyés M., Bácskay I. Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer. J. Pharm. Sci. 2011, 100:4734-4744.